Skip to main content

Peer Review reports

From: CDO1 Promoter Methylation is a Biomarker for Outcome Prediction of Anthracycline Treated, Estrogen Receptor-Positive, Lymph Node-Positive Breast Cancer Patients

Original Submission
30 Jul 2009 Submitted Original manuscript
31 Aug 2009 Reviewed Reviewer Report - Martin Widschwendter
5 Jan 2010 Reviewed Reviewer Report - Kristina Warton
18 Feb 2010 Author responded Author comments - Dimo Dietrich
Resubmission - Version 2
18 Feb 2010 Submitted Manuscript version 2
24 Mar 2010 Reviewed Reviewer Report - Kristina Warton
4 May 2010 Author responded Author comments - Dimo Dietrich
Resubmission - Version 3
4 May 2010 Submitted Manuscript version 3
Publishing
1 Jun 2010 Editorially accepted
1 Jun 2010 Article published 10.1186/1471-2407-10-247

You can find further information about peer review here.

Back to article page